This event serves as a platform for in-depth industrial and technical exchange between Taiwan and Japan, fostering opportunities for resource integration, strategic partnerships, and business collaboration.
The program will feature three thematic presentations covering investment in the biotechnology industry and developments in regenerative medicine. In addition, multiple Taiwanese and Japanese companies will share their research and technologies through company pitch sessions.
By strengthening bilateral cooperation in the biotechnology and pharmaceutical sectors, the event aims to promote industrial development, technological innovation, and international market expansion.
Language:English (Simultaneous Translation NOT available)
Date: Wednesday, April 22, 14:30-18:00
Nihonbashi Life Science HUB
(8F Muromachi Chibagin Mitsui Building 1-5-5, Nihonbashi-muromachi, Chuo-ku, Tokyo)
(Opens an external site)
Program
| Time | Agenda |
| 14:00 - 14:30 | Registration |
| 14:30 - 14:33 | Welcome Address Dr. Michael Huang / Director of BPIPO |
| 14:33 - 14:45 | Opening Remarks Dr. Shiing-Jer Twu / Chairman of DCB Dr. Shunichi Takahashi / President and COO of LINK-J Mr. Kunihiko Suzuki / Chair, Specific Proceeded Cells Committee of FIRM |
| 14:45 - 14:50 | Group Photo Session |
| 14:50 - 15:00 | Investment Landscapes in Taiwan and Japan (TBD) Shuntaro Kodama / Managing Director of DCI Partners |
| 15:00-15:20 | Introduction of Companies –Taiwan 3mins/company |
| 15:20-15:40 | Introduction of Companies – Japan 3mins/company |
| 15:40-16:00 | Break Time |
| 16:00-16:10 | Current Regenerative Medicine Landscape in Taiwan (TBD) Wann Hsin Chen / President of TACT (Taiwan Association for Cellular Therapy) |
| 16:10-16:30 | Introduction of Companies –Taiwan 3mins/company |
| 16:30-16:40 | Current Regenerative Medicine Landscape in Japan (TBD) Dr. Takashi Yamamoto / Chair, International Affairs Committee and CDMO Sub-committee of FIRM |
| 16:40-17:00 | Introduction of Companies – Japan 3mins/company |
| 17:00-18:00 | Attendee Networking |
Speakers
[Participating Companies and Organizations] *Subject to change*
1. Japan:
Forum for Innovative Regenerative Medicine (FIRM)
DCI Partners Co., Ltd.
etc.
[Companies presenting at the pitch section]
Amelieff Corporation
Auxilart Co.,Ltd.
DiveRadGel Co.,Ltd.
SyntheticGestalt KK
2. Taiwan:
Taiwan Association for Cellular Therapy（TACT）
[Companies presenting at the pitch section]
10~15 Companies (TBD)
(with a focus on advanced medicine, precision health and regenerative medicine)
Notice Regarding the Handling of Personal Information
The personal information that you have filled out and submitted will be handled by LINK-J in accordance with the following policy. Photos and videos taken at this event may be used by LINK-J and other related parties on websites, pamphlets, etc.
<<Personal Information Protection Policy>> https://www.link-j.org/en/privacy/
<<Concerning Protection of Personal Information>> https://www.link-j.org/en/use/
Participation Fee
Participation Free
Capacity
150 persons
Organizer
Organized by Biotechnology and Pharmaceutical Industries Promotion Office, MOEA (BPIPO)
Co-organized by Life Science Innovation Network Japan (Link-J) , Development Center for Biotechnology (DCB)
Collaborated by Forum for Innovative Regenerative Medicine (FIRM)
Contact
If you have any questions about this form, please contact to BPIPO:
Cindy: slc@biopharm.org.tw
Lynn: lynn@biopharm.org.tw
